Levalbuterol Hydrochloride

Generic Name: levalbuterol hydrochloride

Over-the-Counter (OTC)

Brand Names:

Levalbuterol

11 DESCRIPTION Levalbuterol Inhalation Solution, USP is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selective beta 2 -adrenergic receptor agonist [see Clinical Pharmacology (12) ].

Overview

Uses

1 INDICATIONS AND USAGE Levalbuterol Inhalation Solution, USP is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. Levalbuterol Inhalation Solution, USP is a beta 2 -adrenergic agonist indicated for: Treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. ( 1 )

Dosage

2 DOSAGE AND ADMINISTRATION Levalbuterol Inhalation Solution, USP is for oral inhalation only. Administer by nebulization using with a standard jet nebulizer (with a face mask or mouthpiece) connected to an air compressor. Do not exceed recommended dose. FOR ORAL INHALATION ONLY ( 2 ) Children 6-11 years old: 0.31 mg administered three times a day, by nebulization. Routine dosing should not exceed 0.63 mg three times a day. ( 2 ) Adults and Adolescents ≥ 12 years old: 0.63 mg administered three times a day, every 6 to 8 hours, by nebulization. The maximum recommended dose is 1.25 mg three times a day. ( 2 ) For use with a standard jet nebulizer (with a face mask or mouthpiece) connected to an air compressor.

Side Effects

6 ADVERSE REACTIONS The following serious adverse reactions are described below and elsewhere in the labeling: Paradoxical bronchospasm [see Warnings and Precautions (5.1) ] Cardiovascular effects [see Warnings and Precautions (5.4) ] Immediate hypersensitivity reactions [see Warnings and Precautions (5.6) ] Hypokalemia [see Warnings and Precautions (5.8) ] Most common adverse reactions are: palpitations, chest pain, tachycardia, headache, dizziness, tremor and nervousness. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Ritedose Pharmaceuticals, LLC at 1-855-806-3300 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

Interactions

7 DRUG INTERACTIONS Other short-acting sympathomimetic aerosol bronchodilators and adrenergic drugs: May potentiate effect. ( 7.1 ) Beta-blockers: May block bronchodilatory effects of beta-agonists and produce severe bronchospasm. Patients with asthma should not normally be treated with beta-blockers. ( 7.2 ) Diuretic: May worsen electrocardiographic changes or hypokalemia associated with diuretic may worsen. Consider monitoring potassium levels. ( 7.3 ) Digoxin: May decrease serum digoxin levels. Consider monitoring digoxin levels. ( 7.4 ) Monoamine oxidase inhibitors (MAOs) or tricyclic antidepressants: May potentiate effect of albuterol on the cardiovascular system. ( 7.5 ) See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.

Warnings

5 WARNINGS AND PRECAUTIONS Life-threatening paradoxical bronchospasm may occur. Discontinue Levalbuterol Inhalation Solution, USP immediately and treat with alternative therapy. ( 5.1 ) Need for more doses of Levalbuterol Inhalation Solution, USP than usual may be a sign of deterioration of asthma and requires reevaluation of treatment. ( 5.2 ) Levalbuterol Inhalation Solution, USP is not a substitute for corticosteroids. ( 5.3 ) Cardiovascular effects may occur. Consider discontinuation of Levalbuterol Inhalation Solution, USP if these effects occur. Use with caution in patients with underlying cardiovascular disorders. ( 5.4 ) Excessive use may be fatal. Do not exceed recommended dose. ( 5.5 ) Immediate hypersensitivity reactions may occur. 4 CONTRAINDICATIONS Levalbuterol Inhalation Solution, USP is contraindicated in patients with a history of hypersensitivity to levalbuterol or racemic albuterol. Reactions have included urticaria, angioedema, rash, bronchospasm, anaphylaxis, and oropharyngeal edema [see Warnings and Precautions (5.6) ]. Hypersensitivity to levalbuterol or racemic albuterol. ( 4 )

Pregnancy

8.1 Pregnancy Risk Summary There are no adequate and well-controlled studies of Levalbuterol Inhalation Solution, USP in pregnant women. There are clinical considerations with the use of Levalbuterol Inhalation Solution, USP in pregnant women [see Clinical Considerations] .

Storage

Store Levalbuterol Inhalation Solution, USP in the protective foil pouch at 20°- 25°C (68°- 77°F) [see USP Controlled Room Temperature]. Protect from light and excessive heat. Keep unopened vials in the foil pouch. Once the foil pouch is opened, the vials should be used within 2 weeks. Vials removed from the pouch, if not used immediately, should be protected from light and used within 1 week.

Frequently Asked Questions

What is Levalbuterol Hydrochloride used for?▼

What are the side effects of Levalbuterol Hydrochloride?▼

Can I take Levalbuterol Hydrochloride during pregnancy?▼

What are the important warnings for Levalbuterol Hydrochloride?▼

Related Medications

Agaricus Musc., Arsenicum Alb., Bismuthum Metallicum, Bryonia, Capsicum, Carbo Veg., Glonoinum, Ipecac., Iris Versicolor, Laurocerasus, Lycopodium, Mezereum, Nux Vom., Pulsatilla, Ranunc. Bulb. , Theridion, Veratrum Alb., Zinc. Met., Zingiber, Chamomilla, Passiflora, Valeriana

agaricus musc., arsenicum alb., bismuthum metallicum, bryonia, capsicum, carbo veg., glonoinum, ipecac., iris versicolor, laurocerasus, lycopodium, mezereum, nux vom., pulsatilla, ranunc. bulb. , theridion, veratrum alb., zinc. met., zingiber, chamomilla, passiflora, valeriana

Non-Standardized Plant Allergenic Extract [EPC]

OTC - PURPOSE SECTION Formulated for symptoms associated with intoxication including nausea, dizziness, discomfort and headache.

Trifolium Pratense

trifolium pratense

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: TRIFOLIUM PRATENSE POLLEN (.001 g/mL). Category: BLA.

Aconiticum Acidum, Cis-, Adenosinum Triphosphoricum Dinatrum, Adrenalinum, , Alpha-ketoglutaricum Acidum, Alpha-lipoicum Acidum, Ascorbicum Acidum, Barium Oxalsuccinicum, Beta Vulgaris, Cerium Oxalicum, Citricum Acidum, Cysteinum, Fumaricum Acidum, Hepar Sulphuris Calcareum, Magnesium Oroticum Dihydricum, Malicum Acidum, Manganum Phosphoricum, Nadidum, Natrum Oxalaceticum, Natrum Pyruvicum, Nicotinamidum, Pantothenic Acid, Proteus (morgani), Pulsatilla (pratensis), Pyridoxinum Hydrochloricum, Riboflavinum,

aconiticum acidum, cis-, adenosinum triphosphoricum dinatrum, adrenalinum, , alpha-ketoglutaricum acidum, alpha-lipoicum acidum, ascorbicum acidum, barium oxalsuccinicum, beta vulgaris, cerium oxalicum, citricum acidum, cysteinum, fumaricum acidum, hepar sulphuris calcareum, magnesium oroticum dihydricum, malicum acidum, manganum phosphoricum, nadidum, natrum oxalaceticum, natrum pyruvicum, nicotinamidum, pantothenic acid, proteus (morgani), pulsatilla (pratensis), pyridoxinum hydrochloricum, riboflavinum,

Calculi Dissolution Agent [EPC]

PURPOSE: Aconiticum Acidum, Cis - Fatigue, Adenosinum Triphosphoricum Dinatrum - Weakness, Adrenalinum - Exhaustion, Alpha-Ketoglutaricum Acidum - Weakness, Alpha-Lipoicum Acidum - Fatigue, Ascorbicum Acidum - Exhaustion, Barium Oxalsuccinicum - Fatigue, Beta Vulgaris - Exhaustion, Cerium Oxalicum - Fatigue, Citricum Acidum - Weakness, Cysteinum - Exhaustion, Fumaricum Acidum - Fatigue, Hepar Sulphuris Calcareum - Fatigue, Magnesium Oroticum Dihydricum - Weakness, Malicum Acidum - Exhaustion, Ma

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.